D2R | DNA to RNA

🔊 #D2RProjectSpotlight: D2R - Health Data Science (D2R-HeDS) platform 💡 Scientific Director: Guillaume Bourque (@McGillu) 🔗 Learn more: buff.ly/qDphDDy
#RNA #RNATherapy #RNAResearch

#D2RProjectSpotlight: End to end sequencing platform for RNA therapeutics quality control (EESPRNATQC) Scientific Director: Ioannis Ragoussis (@mcgillu)🔗 Learn more here: buff.ly/zhzGYc7

🔊 #D2RProjectSpotlight: Centre for Applied Nanomedicine (CAN)💡 Scientific Director: Janusz Rak (RI-MUHC)🧬 Centre for Applied Nanomedicine (CAN) is a place/platform where specialized instruments measure, observe, and characterize myriads of small objects known as nanoparticles 🔗 buff.ly/Hv3NYJV

#BlackHistoryMonth D2R held a webinar on Anti-Black Racism in Health Research. It examined how slavery and anti-Black racism in Canada shaped inequities in health research & the systemic barriers that continue to influence scientific inquiry and health outcomes today. Watch here: buff.ly/uaYFjZA

#D2RProjectSpotlight: RNA therapies for the treatment of a rare neurological disease led by Jo Anne Stratton (@mcgillu) This project aims to understand how RNA-based therapies can be optimized to target Schwann cells, the major cell type affected in Neurofibromatosis type 2.🔗 buff.ly/QYf2Kfg

🔊 #D2RProjectSpotlight: RNA therapeutics to block USP15-driven neuroinflammation in the brain led by Philippe Gros (@mcgillu) this project aims to test the capacity of these USP15 modalities to block neuroinflammation in vivo following delivery to the brain. Learn more: buff.ly/P0QfkgL

🔊 #D2RProjectSpotlight: mRNA Therapy to Prevent Liver Disease Progression in Zellweger Spectrum Disorder led by Nancy Braverman (@McGillu) ZSD is a rare genetic disorder, most patients harbor mutations in PEX1 gene. This project aims to restore PEX1 function. Learn more: buff.ly/3Y93ZQY

🔊 #D2RProjectSpotlight: Aptamer-short hairpin RNA conjugation for gene therapy against HIV led by Anne Gatignol (Jewish General Hospital)🧬This research aims to support a more effective procedure in which a person's own cells are modified to make them resistant to HIV.🔗 buff.ly/WudYn1G

🔊 #D2RProjectSpotlight: Lipid Nanoparticles for Nasal mRNA Vaccines💡 Led by Larry Lands (RI-MUHC) 🧬 This project explores delivering RNA vaccines through a nose spray. This nasal method is not only more convenient but could offer better protection for the lungs. 🔗 Learn more: buff.ly/raSze21

On #WorldCancerDay, we are reminded why research matters. D2R supports research across many types of #cancer, because whether they affect millions or thousands, every diagnosis deserves attention. #cancerresearch #cancerawareness #knowledgetocure

🔊 #D2RProjectSpotlight: 3’UTR engineering for next-generation T cell mRNA therapeutics led by Thomas Duchaine (@mcgillu) This project aims to improve cancer immunotherapies by designing “smart” RNA switches that control how long therapeutic mRNAs stay active in immune cells. buff.ly/iyMZTzA

🔊 #D2RProjectSpotlight: Development of RNA therapeutics against USP15-dependent neuroinflammation led by Philippe Gros, PhD🧬This project aims to develop inhibitors of USP15 which can dampen neuroinflammation using an RNA therapeutics approach. 🔗 Learn more: buff.ly/o3CRrRl

🔊 #D2RProjectSpotlight: Targeting MET exon 14 skipping variant in the early metastatic dissemination in lung cancer 🧬 Led by Morag Park (@mcgillgci.bsky.social) this project aims a novel therapy using targeted molecules designed to block this mutation. 🔗 buff.ly/VfPel6h

#D2RProjectSpotlight: Injectable Hydrogel/mRNA-LNP Platform for In Vivo CAR-T Cell Engineering 🧬Led by Guojun Chen (@McGillu) this project aims to accelerate the development of next-generation immunotherapies buff.ly/Xa2wnaT

#D2RProjectSpotlight: Transient CAR-T Cell engineering🧬Led by Taha Azad (@USherbrooke) this project aims to produce safe & effective CAR-Ts, and help accelerate RNA-based cell therapy development buff.ly/Tsz4eBD

#D2RProjectSpotlight: Development of a new blood test to track treatment success and to detect melanoma returning early🧬Led by Ian Watson (@mcgillu) this project aims to improve care for melanoma patients. buff.ly/7cVwU65

🔊#D2RProjectSpotlight: From #RNA to personalized #lungdisease treatment

🧬Led by David Langlais (@mcgill.ca), this project aims to identify blood markers for earlier diagnosis and personalized treatment of interstitial lung disease (ILD).

🔗https://shorturl.at/yXxOO
#RNA #RNAtherapies

🎯 Want to stay connected to the D2R community?

📩 Subscribe to our newsletter for updates on funded research, events, data science news, EDI, and trainee opportunities: shorturl.at/KynG2

👉 Follow us here and on X, LinkedIn and YouTube for the latest from #D2RMcGill

❄️ Happy Holidays from DNA to RNA! Wishing you all a festive holiday season filled with love and laughter. ❄️

☃️ Communication channels will not be monitored over the holidays (Dec 24- Jan 4), see you in the new year!

🧠 ❤️Join D2R for an EDI seminar about mental health in highly performant spaces in honour of the International Day for Persons with Disabilities

📅 December 3
🕐12–1 PM EST
📍Via Zoom
🔗 Register here: buff.ly/t1gvjy8

🧠 ❤️Join D2R for an EDI seminar about mental health in highly performant spaces in honour of the International Day for Persons with Disabilities

📅 December 3
🕐12–1 PM EST
📍Via Zoom
🔗 Register here: buff.ly/t1gvjy8

Join D2R for the next session of the D2R Investor Series with Inès Holzbaur, an experienced investor who will demystify the industry.

📅 28 November 2025
🕚 11:00 –1:00
📍Attend in person or via Zoom.

Register here: buff.ly/tcFaGmP

#Startups #Investing

D2R's EDI Action Plan D2R’s EDI Action Plan was developed through a collaborative process involving equity-deserving groups, researchers, staff, and partners, with the goal of transforming good intentions into meaningful…

💡 Curious about how D2R is turning its Equity, Diversity, and Inclusion (EDI) vision into action?

D2R’s EDI Action Plan was developed through a collaborative process, and outlines key initiatives across three key focus areas

🔗 Learn more:

🧬 D2R invests over $5.3 million in research and $3.9 million in training to advance RNA innovation across Canada over the next two years.

🔗 Foundational Projects | Cycle 2: buff.ly/rDRhJ85
🔗 Research in Motion Projects | Cycle 2: buff.ly/ZCjFser

#RNAResearch #Innovation

🧬 Professor Carl Ernst and his team are leading a groundbreaking RNA therapy project aimed at treating Schinzel-Giedion Syndrome supported by D2R’s Translational Impact Research program.

🔗 Learn more: buff.ly/0X51szG

#RareDisease #RNAtherapy
@mcgillscience.bsky.social
@theneuro.bsky.social

🎉 We are proud to launch our Equity, Diversity, and Inclusion (EDI) Action Plan!

✨EDI is at the core of D2R’s vision, and the document outlines our current and upcoming EDI initiatives across three key focus areas.

Read the Action Plan now: buff.ly/bEybZGg

Hear from Philippe Gros, Loretta Catherine Loon, and Laurie Montour on how D2R’s Indigenous engagement initiatives are fostering respectful, community-driven collaborations that strengthen research,… Indigenous Engagement at D2R | With Philippe Gros, Loretta Catherine Loon & Laurie Montour

🌿 At D2R, Indigenous engagement is at the heart of our approach. Hear from Philippe Gros, Loretta Loon, and Laurie Montour on how D2R is bringing Indigenous voices into RNA Research.

🔗 Watch now: buff.ly/uQ7jgKO
#IndigenousEngagement #RNAResearch

🧠 Imagine learning your child has a rare brain disorder—and no cure.

💡 With D2R support, Dr. Geneviève Bernard is developing RNA-based therapies to bring hope to families facing that reality.

🔗Read more: buff.ly/2iZEcB3

#RNA #RareDisease #Neuroscience #PrecisionMedicine

🌸 This Wednesday! 🌸

Join D2R , mcgillgci.bsky.social , the Quebec Breast Cancer Foundation, and Audace au Féminin for an inspiring evening to honour breast cancer awareness month!

📅 Wednesday, October 22, 2025
🕔 5:00 – 8:30 PM
📍 Atrium, Bellini Centre

Register: buff.ly/C64fHgE

In Person Event | Breast Cancer & RNA Therapeutics: Exploring Join D2R and the Rosalind and Morris Goodman Cancer Institute (GCI) for an event in honour of Breast Cancer Awareness Month and Women's History Month, in collaboration with Fondation du cancer du sein...

🌸 In Honour of Breast Cancer Awareness Month join D2R , mcgillgci.bsky.social , the Quebec Breast Cancer Foundation, and Audace au Féminin for an inspiring evening!

📅 Wednesday, October 22, 2025
🕔 5:00 – 8:30 PM
📍 Atrium, Bellini Centre

Register: buff.ly/C64fHgE
#BreastCancerAwareness #RNA